Insider Trading History of Buckley Stephen Jr.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Buckley Stephen Jr. since 2014. The trader's CIK number is 1571830. At the time of the last reporting, Buckley Stephen Jr. was the Director of Novus Therapeutics, Inc.. (stock ticker symbol NVUS). Also see all insider trading activities at Novus Therapeutics, Inc..

Note that in the past Buckley Stephen Jr. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Enanta Pharmaceuticals Inc (ENTA) by Buckley Stephen Jr.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 ENTA 1,000 $33,996 0 $0 0 $0
2014 ENTA 1,000 $38,950 0 $0 0 $0

Yearly summary of insider trading at Novus Therapeutics, Inc. (TKAI) by Buckley Stephen Jr.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 TKAI 8,000 $45,920 0 $0 0 $0
2015 TKAI 3,000 $33,750 0 $0 0 $0


Insider trading activities at 2 companies by Buckley Stephen Jr.:

1. Enanta Pharmaceuticals Inc (ENTA)

2. Novus Therapeutics, Inc. (TKAI)

Table 1. Insider trading of Enanta Pharmaceuticals Inc (ENTA) by Buckley Stephen Jr.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-02-19 ENTA Buy 600 34.20 20,520
2015-02-18 ENTA Buy 400 33.69 13,476
2014-08-14 ENTA Buy 1,000 38.95 38,950

Table 2. Insider trading of Novus Therapeutics, Inc. (TKAI) by Buckley Stephen Jr.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-03-15 TKAI Buy 8,000 5.74 45,920
2015-11-11 TKAI Buy 3,000 11.25 33,750

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Buckley Stephen Jr. (Director of Novus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.